H-E-B recalled 300,000 units of inControl Sterile Alcohol Pads on July 7, 2025. The recall follows reports that isopropyl alcohol levels fall below the labeled concentration. Consumers should stop using the product immediately.
Subpotent Drug- isopropyl alcohol levels fall below the labeled concentration.
Consumers and healthcare providers should stop using this product immediately. Contact MEDLINE INDUSTRIES, LP - Northfield or your healthcare provider for guidance. Notification method: Letter
The recalled product is inControl Sterile Alcohol Pads, packaged in boxes of 100. The affected product has the NDC number 37808-809-09 and was distributed nationwide.
The alcohol pads are subpotent, meaning they do not contain the labeled concentration of isopropyl alcohol. This could lead to ineffective disinfection, posing a risk of infection.
No specific injuries or incidents have been reported to date regarding this product. The recall is precautionary due to the subpotent nature of the drug.
Consumers should stop using the alcohol pads immediately. Contact Medline Industries at the provided contact for guidance and potential refund options.
For further information, contact Medline Industries, LP at 1-800-633-5463 or visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0603-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.